Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Dr Lal PathLabs posted a 27% rise in second-quarter profit on Wednesday, reaching 1.92 billion rupees.
- ✓Higher demand for preventive health check-ups helped the company, as it tested 13.6% more samples.
- ✓CFO Ved Goel said, "The diagnostics industry continues to benefit from increasing healthcare awareness and rising adoption of check-ups."
Story at a Glance
- Category
- BUSINESS
- Reported By
- Economic Times
- Reading Speed
- 2 Minute(s)
- Market Focus
- India Economy
Dr Lal PathLabs announced a 27% increase in its second-quarter profit, with net earnings rising to 1.92 billion rupees. The company experienced a near 20% increase in consolidated revenue from operations during this period. A rise in healthcare awareness has fueled the demand for preventive health check-ups, contributing to these earnings. Dr Lal tested 13.6% more samples this quarter compared to the previous year.
Dr Lal PathLabs posted a more than 27% rise in second-quarter profit on Wednesday, helped by higher test volumes and demand for preventive health packages.
The Indian lab operator's consolidated net profit for the three months ended September 30 rose to 1.92 billion rupees ($20.27 million), from 1.51 billion rupees a year earlier.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Economic Times
Read the full, original unfiltered story directly on the publisher's portal.